• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

银杏叶提取物治疗外周动脉闭塞性疾病患者期间的血液流变学与行走情况

Hemorheology and walking of peripheral arterial occlusive diseases patients during treatment with Ginkgo biloba extract.

作者信息

Li A L, Shi Y D, Landsmann B, Schanowski-Bouvier P, Dikta G, Bauer U, Artmann G M

机构信息

Department of Applied Cell Biophysics and Bioengineering, Aachen University of Applied Sciences, Jülich, Germany.

出版信息

Zhongguo Yao Li Xue Bao. 1998 Sep;19(5):417-21.

PMID:10375799
Abstract

AIM

To study the effects of Ginkgo biloba extract 761 (GbE) from the points of view of hemorheology for patients of peripheral arterial occlusive diseases (PAOD).

METHODS

The treatment with GbE (240 mg.d-1, po) and the pain-free walking distance (PFWD) were carried out for 24 PAOD patients (12 nondiabetic, ND and 12 diabetic, D) over 48 wk. The parameters erythrocyte stiffness (ES) and relaxation time (RT), the blood plasma viscosity (eta), the plasma fibrinogen concentration (Cf) and the blood sedimentation rate (BSR), the PFWD, and maximal walking distance (MWD) were determined at 6 wk before treatment (-6), at the beginning of the treatment (0), and after 6, 11, 16, and 48 wk of treatment.

RESULTS

At wk -6, ES and RT of both the ND- and D-group were not significantly different from a healthy control group. At wk 0, stiffness and RT were significantly higher than healthy control, and the mean PFWD was only 111 m. The eta value was significantly elevated and Cf and BSR were enhanced. Throughout 11 wk of treatment ES, RT, eta, and Cf decreased gradually and PFWD improved. Between 16 and 48 wk, ES, and RT were no longer significantly different from the controls, whereas eta and Cf decreased gradually but remained higher than normal, BSR decreased, and the PFWD improved by a factor of 3.8 times (D) and 3.3 times (ND).

CONCLUSION

GbE gives therapeutic effects in PAOD patients.

摘要

目的

从血液流变学角度研究银杏叶提取物761(GbE)对周围动脉闭塞性疾病(PAOD)患者的影响。

方法

对24例PAOD患者(12例非糖尿病患者,ND;12例糖尿病患者,D)采用GbE(240mg·d-1,口服)治疗并进行无痛步行距离(PFWD)测定,疗程48周。在治疗前6周(-6)、治疗开始时(0)以及治疗6、11、16和48周后测定红细胞刚性(ES)和松弛时间(RT)、血浆黏度(η)、血浆纤维蛋白原浓度(Cf)和血沉率(BSR)、PFWD以及最大步行距离(MWD)。

结果

在-6周时,ND组和D组的ES和RT与健康对照组相比无显著差异。在0周时,刚性和RT显著高于健康对照组,平均PFWD仅为111m。η值显著升高且Cf和BSR升高。在整个11周的治疗过程中,ES、RT、η和Cf逐渐降低,PFWD改善。在16至48周期间,ES和RT与对照组不再有显著差异,而η和Cf逐渐降低但仍高于正常水平,BSR降低,PFWD改善了3.8倍(D组)和3.3倍(ND组)。

结论

GbE对PAOD患者有治疗作用。

相似文献

1
Hemorheology and walking of peripheral arterial occlusive diseases patients during treatment with Ginkgo biloba extract.银杏叶提取物治疗外周动脉闭塞性疾病患者期间的血液流变学与行走情况
Zhongguo Yao Li Xue Bao. 1998 Sep;19(5):417-21.
2
Comparison of two dosages of ginkgo biloba extract EGb 761 in patients with peripheral arterial occlusive disease Fontaine's stage IIb. A randomised, double-blind, multicentric clinical trial.两种剂量银杏叶提取物EGb 761用于外周动脉闭塞性疾病Fontaine IIb期患者的比较:一项随机、双盲、多中心临床试验。
Arzneimittelforschung. 1999 Nov;49(11):900-4. doi: 10.1055/s-0031-1300524.
3
[Effects of the leaf of Ginkgo biloba L. extract on blood rheology in animals].[银杏叶提取物对动物血液流变学的影响]
Zhongguo Zhong Yao Za Zhi. 1998 Oct;23(10):622-3, 640- inside back cover.
4
[Effects of Qiang Gu Kang Wei compound on hemorheology in tail-suspended rats].强骨抗萎复方对尾部悬吊大鼠血液流变学的影响
Space Med Med Eng (Beijing). 2002 Oct;15(5):327-30.
5
[The evaluation by video capillaroscopy of the efficacy of a Ginkgo biloba extract with L-arginine and magnesium in the treatment of trophic lesions in patients with stage-IV chronic obliterating arteriopathy].[采用视频毛细血管显微镜评估含L-精氨酸和镁的银杏叶提取物治疗IV期慢性闭塞性动脉病患者营养性病变的疗效]
Minerva Cardioangiol. 1999 Jun;47(6):223-30.
6
Supervised exercise training combined with ginkgo biloba treatment for patients with peripheral arterial disease.监督性运动训练联合银杏叶治疗外周动脉疾病患者。
Clin Rehabil. 2007 Jul;21(7):579-86. doi: 10.1177/0269215507075205.
7
Effects of a 4-week treatment with prostaglandin E1 on plasma endothelin-1 release in patients with intermittent claudication.前列腺素E1治疗4周对间歇性跛行患者血浆内皮素-1释放的影响。
Int J Clin Pharmacol Ther. 1999 Jul;37(7):347-51.
8
Influence of controlled vascular training on the pain free walking distance and plasmaviscosity in patients suffering from peripheral arterial occlusive disease.控制性血管训练对周围动脉闭塞性疾病患者无痛步行距离和血浆粘度的影响。
Clin Hemorheol Microcirc. 2009;41(1):73-80. doi: 10.3233/CH-2009-1157.
9
Hypervolumetric hemodilution with HES 100/0.5 10% in patients with peripheral arterial occlusive disease (Fontaine, stage II): an open clinical and pharmacological phase IV study.
Clin Hemorheol Microcirc. 2000;22(1):53-65.
10
Ginkgo biloba leaf extract enhances levels of caspase-3 and amyloid precursor protein in normal rat hippocampus.银杏叶提取物可提高正常大鼠海马体中半胱天冬酶 - 3和淀粉样前体蛋白的水平。
Acta Pharmacol Sin. 2003 Feb;24(2):152-6.

引用本文的文献

1
Ginkgo biloba for intermittent claudication.银杏叶治疗间歇性跛行。
Cochrane Database Syst Rev. 2013 Jun 6;2013(6):CD006888. doi: 10.1002/14651858.CD006888.pub3.